Abstract
Alcohol and hepatotropic viruses cause the majority of liver cirrhosis cases in the Western World. Colchicine is an anti-inflammatory and anti-fibrotic medication. Several randomised clinical trials have addressed the question whether colchicine has any efficacy in patients with alcoholic or non-alcoholic fibrosis and cirrhosis.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Cochrane Database of Systematic Reviews |
Udgave nummer | 2 |
Sider (fra-til) | CD002148 |
ISSN | 1469-493X |
DOI | |
Status | Udgivet - 2005 |